Stay updated with breaking news from Development Command Under Contract No. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Cellphire Therapeutics, Inc., a biotechnology company developing next-generation pooled allogeneic cellular therapeutics for application across...
Cellphire Therapeutics Names Michael Gaffney as Company's New CEO News provided by Share this article Share this article ROCKVILLE, Md., April 20, 2021 /PRNewswire/ -- Cellphire Therapeutics, Inc., a biotechnology company developing next-generation platelet-based hemostatic therapeutics for application across multiple medical indications, announced today that Michael Gaffney has joined the company as Chief Executive Officer, effective immediately. Mr. Gaffney brings deep health sector insight, extensive operational experience, and proven strategy and capital markets expertise to Cellphire. H...